Table 1.
Demographics and baseline characteristics of 60 patients with COVID-2019 admitted to Jinyintan Hospital in Wuhan.
| Variables | Group A (n=20) | Group B (n=20) | Group C (n=20) | Total (n=60) | p-value |
|---|---|---|---|---|---|
| Age (n, %) | |||||
| Median (IQR) -year | 54.5 (42.8-67.0) | 52.0 (38.3-60.5) | 62.5 (45.8-67.5) | 54.5 (45.0-64.8) | |
| < 40 | 4 (20.0%) | 5 (25.0%) | 1 (5.0%) | 10 (16.7%) | 0.27* |
| 40-65 | 11 (55.0%) | 13 (65.0%) | 13 (65.0%) | 37 (61.7%) | |
| > 65 | 5 (25.0%) | 2 (10.0%) | 6 (30.0%) | 13 (21.7%) | |
| Sex (n, %) | |||||
| Male | 18 (90.0%) | 7 (35.0%) | 15 (75.0%) | 40 (66.7%) | 0.00069 |
| Female | 2 (10.0%) | 13 (65.0%) | 5 (25.0%) | 20 (33.3%) | |
| Chronic medical illness (n, %) | 11 (55.0%) | 9 (45.0%) | 15 (75.0%) | 35 (58.3%) | 0.15 |
| Cardiovascular and cerebrovascular diseases | 8 (40.0%) | 4 (20.0%) | 10 (50.0%) | 22 (36.7%) | 0.13 |
| Digestive system disease | 2 (10.0%) | 1 (5.0%) | 4 (20.0%) | 7 (11.7%) | 0.48* |
| Endocrine system disease | 1 (5.0%) | 3 (15.0%) | 5 (25.0%) | 9 (15.0%) | 0.27* |
| Malignant tumor | 1 (5.0%) | 3 (15.0%) | 1 (5.0%) | 5 (8.3%) | 0.60* |
| Nervous system disease | 0 (0.0%) | 0(0.0%) | 3 (15.0%) | 3 (5.0%) | 0.10* |
| Respiratory system disease | 0 (0.0%) | 1 (5.0%) | 4 (20.0%) | 5 (8.3%) | 0.12* |
| Other | 3 (15.0%) | 1 (5.0%) | 2 (10.0%) | 6 (10.0%) | 0.86* |
| Fever (n, %) | 8 (40.0%) | 7 (35.0%) | 3 (15.0%) | 18 (30.0%) | 0.19 |
COVID-2019 = Corona Virus Disease 2019; Group A = Lopinavir-Ritonavir; Group B = Huashi Baidu Formula + Lopinavir-Ritonavir; Group C = Huashi Baidu Formula; IQR ==interquartile range; * ==Fisher's exact test